EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-07-04

AUTHORS

F Cidre-Aranaz, T G P Grünewald, D Surdez, L García-García, J Carlos Lázaro, T Kirchner, L González-González, A Sastre, P García-Miguel, S E López-Pérez, S Monzón, O Delattre, J Alonso

ABSTRACT

Ewing sarcoma is characterized by chromosomal translocations fusing the EWS gene with various members of the ETS family of transcription factors, most commonly FLI1. EWS-FLI1 is an aberrant transcription factor driving Ewing sarcoma tumorigenesis by either transcriptionally inducing or repressing specific target genes. Herein, we showed that Sprouty 1 (SPRY1), which is a physiological negative feedback inhibitor downstream of fibroblast growth factor (FGF) receptors (FGFRs) and other RAS-activating receptors, is an EWS-FLI1 repressed gene. EWS-FLI1 knockdown specifically increased the expression of SPRY1, while other Sprouty family members remained unaffected. Analysis of SPRY1 expression in a panel of Ewing sarcoma cells showed that SPRY1 was not expressed in Ewing sarcoma cell lines, suggesting that it could act as a tumor suppressor gene in these cells. In agreement, induction of SPRY1 in three different Ewing sarcoma cell lines functionally impaired proliferation, clonogenic growth and migration. In addition, SPRY1 expression inhibited extracellular signal-related kinase/mitogen-activated protein kinase (MAPK) signaling induced by serum and basic FGF (bFGF). Moreover, treatment of Ewing sarcoma cells with the potent FGFR inhibitor PD-173074 reduced bFGF-induced proliferation, colony formation and in vivo tumor growth in a dose-dependent manner, thus mimicking SPRY1 activity in Ewing sarcoma cells. Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort. Taken together, our data indicate that EWS-FLI1-mediated repression of SPRY1 leads to unrestrained bFGF-induced cell proliferation, suggesting that targeting the FGFR/MAPK pathway can constitute a promising therapeutic approach for this devastating disease. More... »

PAGES

766-776

References to SciGraph publications

  • 2010-07-06. Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1–PI3K–Rac1 pathway in BRITISH JOURNAL OF CANCER
  • 2014-06-08. The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells in JOURNAL OF OVARIAN RESEARCH
  • 1997-10-30. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors in ONCOGENE
  • 2015-07-27. Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite in NATURE GENETICS
  • 2011-12-12. Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma in ONCOGENE
  • 2012-02-12. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma in NATURE GENETICS
  • 2014-02-08. Human Sprouty1 suppresses growth, migration, and invasion in human breast cancer cells in TUMOR BIOLOGY
  • 2008-06-30. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells in ONCOGENE
  • 2003-05. Split personalities: the agonistic antagonist Sprouty in NATURE CELL BIOLOGY
  • 2012-03-28. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity in NATURE
  • 1992-09. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours in NATURE
  • 2003-05-22. Response of Ewing tumor cells to forced and activated p53 expression in ONCOGENE
  • 1999-10. Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein in NATURE GENETICS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/onc.2016.244

    DOI

    http://dx.doi.org/10.1038/onc.2016.244

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1018729222

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/27375017


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Heterografts", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "MAP Kinase Signaling System", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice, SCID", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oncogene Proteins, Fusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Protein c-fli-1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA-Binding Protein EWS", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sarcoma, Ewing", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Signal Transduction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "ras Proteins", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
              "id": "http://www.grid.ac/institutes/grid.413448.e", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Cidre-Aranaz", 
            "givenName": "F", 
            "id": "sg:person.01241144177.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241144177.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany", 
              "id": "http://www.grid.ac/institutes/grid.5252.0", 
              "name": [
                "INSERM U830 \u2018Genetics and Biology of Cancers\u2019 Institut Curie Research Center, Paris, France", 
                "Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gr\u00fcnewald", 
            "givenName": "T G P", 
            "id": "sg:person.07476145564.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07476145564.93"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "INSERM U830 \u2018Genetics and Biology of Cancers\u2019 Institut Curie Research Center, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.418596.7", 
              "name": [
                "INSERM U830 \u2018Genetics and Biology of Cancers\u2019 Institut Curie Research Center, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Surdez", 
            "givenName": "D", 
            "id": "sg:person.01014131131.48", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014131131.48"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
              "id": "http://www.grid.ac/institutes/grid.413448.e", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garc\u00eda-Garc\u00eda", 
            "givenName": "L", 
            "id": "sg:person.01046236753.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046236753.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
              "id": "http://www.grid.ac/institutes/grid.413448.e", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Carlos L\u00e1zaro", 
            "givenName": "J", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany", 
              "id": "http://www.grid.ac/institutes/grid.5252.0", 
              "name": [
                "Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kirchner", 
            "givenName": "T", 
            "id": "sg:person.0650074000.01", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650074000.01"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
              "id": "http://www.grid.ac/institutes/grid.413448.e", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gonz\u00e1lez-Gonz\u00e1lez", 
            "givenName": "L", 
            "id": "sg:person.010517700551.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010517700551.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad hemato-oncolog\u00eda pedi\u00e1trica, Hospital Infantil Universitario La Paz, Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/grid.81821.32", 
              "name": [
                "Unidad hemato-oncolog\u00eda pedi\u00e1trica, Hospital Infantil Universitario La Paz, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sastre", 
            "givenName": "A", 
            "id": "sg:person.010652500611.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010652500611.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad hemato-oncolog\u00eda pedi\u00e1trica, Hospital Infantil Universitario La Paz, Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/grid.81821.32", 
              "name": [
                "Unidad hemato-oncolog\u00eda pedi\u00e1trica, Hospital Infantil Universitario La Paz, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garc\u00eda-Miguel", 
            "givenName": "P", 
            "id": "sg:person.01176025111.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176025111.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
              "id": "http://www.grid.ac/institutes/grid.413448.e", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "L\u00f3pez-P\u00e9rez", 
            "givenName": "S E", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER U758), Instituto de Salud Carlos III, Madrid, Spain", 
              "id": "http://www.grid.ac/institutes/grid.452372.5", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
                "Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Raras (CIBERER U758), Instituto de Salud Carlos III, Madrid, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Monz\u00f3n", 
            "givenName": "S", 
            "id": "sg:person.01021230763.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021230763.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "INSERM U830 \u2018Genetics and Biology of Cancers\u2019 Institut Curie Research Center, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.418596.7", 
              "name": [
                "INSERM U830 \u2018Genetics and Biology of Cancers\u2019 Institut Curie Research Center, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Delattre", 
            "givenName": "O", 
            "id": "sg:person.01346440237.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346440237.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain", 
              "id": "http://www.grid.ac/institutes/grid.413448.e", 
              "name": [
                "Unidad de Tumores S\u00f3lidos Infantiles, Instituto de Investigaci\u00f3n de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Alonso", 
            "givenName": "J", 
            "id": "sg:person.012571320022.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012571320022.50"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/359162a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008302153", 
              "https://doi.org/10.1038/359162a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2008.203", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044394606", 
              "https://doi.org/10.1038/onc.2008.203"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1206391", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007451007", 
              "https://doi.org/10.1038/sj.onc.1206391"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncb0503-377", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045957077", 
              "https://doi.org/10.1038/ncb0503-377"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s13277-014-1665-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020218086", 
              "https://doi.org/10.1007/s13277-014-1665-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1757-2215-7-61", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032021446", 
              "https://doi.org/10.1186/1757-2215-7-61"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature11003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036060000", 
              "https://doi.org/10.1038/nature11003"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/13854", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041243219", 
              "https://doi.org/10.1038/13854"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng.1085", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025499740", 
              "https://doi.org/10.1038/ng.1085"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2011.556", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010799271", 
              "https://doi.org/10.1038/onc.2011.556"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6605775", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028392141", 
              "https://doi.org/10.1038/sj.bjc.6605775"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1201397", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004676244", 
              "https://doi.org/10.1038/sj.onc.1201397"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng.3363", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033290656", 
              "https://doi.org/10.1038/ng.3363"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2016-07-04", 
        "datePublishedReg": "2016-07-04", 
        "description": "Ewing sarcoma is characterized by chromosomal translocations fusing the EWS gene with various members of the ETS family of transcription factors, most commonly FLI1. EWS-FLI1 is an aberrant transcription factor driving Ewing sarcoma tumorigenesis by either transcriptionally inducing or repressing specific target genes. Herein, we showed that Sprouty 1 (SPRY1), which is a physiological negative feedback inhibitor downstream of fibroblast growth factor (FGF) receptors (FGFRs) and other RAS-activating receptors, is an EWS-FLI1 repressed gene. EWS-FLI1 knockdown specifically increased the expression of SPRY1, while other Sprouty family members remained unaffected. Analysis of SPRY1 expression in a panel of Ewing sarcoma cells showed that SPRY1 was not expressed in Ewing sarcoma cell lines, suggesting that it could act as a tumor suppressor gene in these cells. In agreement, induction of SPRY1 in three different Ewing sarcoma cell lines functionally impaired proliferation, clonogenic growth and migration. In addition, SPRY1 expression inhibited extracellular signal-related kinase/mitogen-activated protein kinase (MAPK) signaling induced by serum and basic FGF (bFGF). Moreover, treatment of Ewing sarcoma cells with the potent FGFR inhibitor PD-173074 reduced bFGF-induced proliferation, colony formation and in vivo tumor growth in a dose-dependent manner, thus mimicking SPRY1 activity in Ewing sarcoma cells. Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort. Taken together, our data indicate that EWS-FLI1-mediated repression of SPRY1 leads to unrestrained bFGF-induced cell proliferation, suggesting that targeting the FGFR/MAPK pathway can constitute a promising therapeutic approach for this devastating disease.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/onc.2016.244", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1097543", 
            "issn": [
              "0950-9232", 
              "1476-5594"
            ], 
            "name": "Oncogene", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "36"
          }
        ], 
        "keywords": [
          "mitogen-activated protein kinase", 
          "fibroblast growth factor receptor", 
          "EWS-FLI1", 
          "transcription factors", 
          "Sprouty-1", 
          "Sprouty family members", 
          "kinase/mitogen-activated protein kinase", 
          "basic FGF", 
          "specific target genes", 
          "aberrant transcription factor", 
          "sarcoma cell lines", 
          "SPRY1 expression", 
          "negative feedback inhibitor", 
          "cell lines", 
          "sarcoma cells", 
          "tumor suppressor gene", 
          "high expression levels", 
          "Ewing's sarcoma cell lines", 
          "protein kinase", 
          "growth factor receptor", 
          "target genes", 
          "ETS family", 
          "vivo tumor growth", 
          "sarcoma tumorigenesis", 
          "feedback inhibitor", 
          "MAPK pathway", 
          "suppressor gene", 
          "chromosomal translocations", 
          "genes", 
          "Ewing sarcoma tumors", 
          "colony formation", 
          "factor receptor", 
          "expression levels", 
          "cell proliferation", 
          "EWS gene", 
          "devastating disease", 
          "clonogenic growth", 
          "expression", 
          "dose-dependent manner", 
          "cells", 
          "proliferation", 
          "tumor growth", 
          "family members", 
          "repression", 
          "kinase", 
          "receptors", 
          "knockdown", 
          "FLI1", 
          "sarcoma tumors", 
          "FGF", 
          "translocation", 
          "members", 
          "growth", 
          "tumorigenesis", 
          "large patient cohort", 
          "promising therapeutic approach", 
          "pathway", 
          "therapeutic approaches", 
          "lines", 
          "patient cohort", 
          "improved outcomes", 
          "induction", 
          "family", 
          "inhibitors", 
          "migration", 
          "sarcoma", 
          "tumors", 
          "suppression", 
          "aggressiveness", 
          "activity", 
          "factors", 
          "manner", 
          "formation", 
          "cohort", 
          "levels", 
          "disease", 
          "addition", 
          "outcomes", 
          "Herein", 
          "treatment", 
          "analysis", 
          "panel", 
          "data", 
          "approach", 
          "agreement"
        ], 
        "name": "EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma", 
        "pagination": "766-776", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1018729222"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/onc.2016.244"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "27375017"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/onc.2016.244", 
          "https://app.dimensions.ai/details/publication/pub.1018729222"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:32", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_707.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/onc.2016.244"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.244'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.244'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.244'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/onc.2016.244'


     

    This table displays all metadata directly associated to this object as RDF triples.

    367 TRIPLES      22 PREDICATES      142 URIs      120 LITERALS      24 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/onc.2016.244 schema:about N137e302b723d4f6f8cee72892dfc7b41
    2 N19fa6482e4b346e7a49592b053aa0712
    3 N1e636ed48ea645508a1e1ff3737d4194
    4 N216f0031848241a28e5542faa189ef9e
    5 N25f46e19cb304f639b8507cdb49308f1
    6 N2703ebf51dde4552b27c4d971fdccb5d
    7 N27cea2318f834c05baf922cbda096395
    8 N4deedafbaa2a485292d5c083062dcdcf
    9 N563fc33cbe3a4c8d8cf81a5be0ade72c
    10 N76245a496984404e9c9ff2059d7eade4
    11 N7f412ed731ff481599058b37d96c9362
    12 N7f585fa48b584570b4e8e1e1ee3317f6
    13 N8c28822bd1664677af21f484081dac45
    14 Na6b11daddd5742038f75bac31f5be83d
    15 Nafe582d236f746d1b38e5cebbdc4a73d
    16 Nb4cb96cbfe5541c9bbc9854e8ee507aa
    17 Ne360ca9dd230448aba5dac50417ffe9e
    18 anzsrc-for:11
    19 anzsrc-for:1103
    20 anzsrc-for:1112
    21 schema:author Nfb07bd4e1e8c48cdaede6162308037c6
    22 schema:citation sg:pub.10.1007/s13277-014-1665-y
    23 sg:pub.10.1038/13854
    24 sg:pub.10.1038/359162a0
    25 sg:pub.10.1038/nature11003
    26 sg:pub.10.1038/ncb0503-377
    27 sg:pub.10.1038/ng.1085
    28 sg:pub.10.1038/ng.3363
    29 sg:pub.10.1038/onc.2008.203
    30 sg:pub.10.1038/onc.2011.556
    31 sg:pub.10.1038/sj.bjc.6605775
    32 sg:pub.10.1038/sj.onc.1201397
    33 sg:pub.10.1038/sj.onc.1206391
    34 sg:pub.10.1186/1757-2215-7-61
    35 schema:datePublished 2016-07-04
    36 schema:datePublishedReg 2016-07-04
    37 schema:description Ewing sarcoma is characterized by chromosomal translocations fusing the EWS gene with various members of the ETS family of transcription factors, most commonly FLI1. EWS-FLI1 is an aberrant transcription factor driving Ewing sarcoma tumorigenesis by either transcriptionally inducing or repressing specific target genes. Herein, we showed that Sprouty 1 (SPRY1), which is a physiological negative feedback inhibitor downstream of fibroblast growth factor (FGF) receptors (FGFRs) and other RAS-activating receptors, is an EWS-FLI1 repressed gene. EWS-FLI1 knockdown specifically increased the expression of SPRY1, while other Sprouty family members remained unaffected. Analysis of SPRY1 expression in a panel of Ewing sarcoma cells showed that SPRY1 was not expressed in Ewing sarcoma cell lines, suggesting that it could act as a tumor suppressor gene in these cells. In agreement, induction of SPRY1 in three different Ewing sarcoma cell lines functionally impaired proliferation, clonogenic growth and migration. In addition, SPRY1 expression inhibited extracellular signal-related kinase/mitogen-activated protein kinase (MAPK) signaling induced by serum and basic FGF (bFGF). Moreover, treatment of Ewing sarcoma cells with the potent FGFR inhibitor PD-173074 reduced bFGF-induced proliferation, colony formation and in vivo tumor growth in a dose-dependent manner, thus mimicking SPRY1 activity in Ewing sarcoma cells. Although the expression of SPRY1 was low when compared with other tumors, SPRY1 was variably expressed in primary Ewing sarcoma tumors and higher expression levels were significantly associated with improved outcome in a large patient cohort. Taken together, our data indicate that EWS-FLI1-mediated repression of SPRY1 leads to unrestrained bFGF-induced cell proliferation, suggesting that targeting the FGFR/MAPK pathway can constitute a promising therapeutic approach for this devastating disease.
    38 schema:genre article
    39 schema:inLanguage en
    40 schema:isAccessibleForFree true
    41 schema:isPartOf N65681fd6e7484a0fb37101f8c491fe7e
    42 Ncbb76fd5f4ec46bdb3c4e295cc97ecad
    43 sg:journal.1097543
    44 schema:keywords ETS family
    45 EWS gene
    46 EWS-FLI1
    47 Ewing sarcoma tumors
    48 Ewing's sarcoma cell lines
    49 FGF
    50 FLI1
    51 Herein
    52 MAPK pathway
    53 SPRY1 expression
    54 Sprouty family members
    55 Sprouty-1
    56 aberrant transcription factor
    57 activity
    58 addition
    59 aggressiveness
    60 agreement
    61 analysis
    62 approach
    63 basic FGF
    64 cell lines
    65 cell proliferation
    66 cells
    67 chromosomal translocations
    68 clonogenic growth
    69 cohort
    70 colony formation
    71 data
    72 devastating disease
    73 disease
    74 dose-dependent manner
    75 expression
    76 expression levels
    77 factor receptor
    78 factors
    79 family
    80 family members
    81 feedback inhibitor
    82 fibroblast growth factor receptor
    83 formation
    84 genes
    85 growth
    86 growth factor receptor
    87 high expression levels
    88 improved outcomes
    89 induction
    90 inhibitors
    91 kinase
    92 kinase/mitogen-activated protein kinase
    93 knockdown
    94 large patient cohort
    95 levels
    96 lines
    97 manner
    98 members
    99 migration
    100 mitogen-activated protein kinase
    101 negative feedback inhibitor
    102 outcomes
    103 panel
    104 pathway
    105 patient cohort
    106 proliferation
    107 promising therapeutic approach
    108 protein kinase
    109 receptors
    110 repression
    111 sarcoma
    112 sarcoma cell lines
    113 sarcoma cells
    114 sarcoma tumorigenesis
    115 sarcoma tumors
    116 specific target genes
    117 suppression
    118 suppressor gene
    119 target genes
    120 therapeutic approaches
    121 transcription factors
    122 translocation
    123 treatment
    124 tumor growth
    125 tumor suppressor gene
    126 tumorigenesis
    127 tumors
    128 vivo tumor growth
    129 schema:name EWS-FLI1-mediated suppression of the RAS-antagonist Sprouty 1 (SPRY1) confers aggressiveness to Ewing sarcoma
    130 schema:pagination 766-776
    131 schema:productId N5dcf0c43e88b44e0b570dd0d644fda39
    132 Nbc577df8ad254915918581966cc962ef
    133 Ncb2f4a1c7bdf41f18f854bb86b8d2147
    134 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018729222
    135 https://doi.org/10.1038/onc.2016.244
    136 schema:sdDatePublished 2022-05-20T07:32
    137 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    138 schema:sdPublisher N9bde318227cf4230b3a370a08bd39ed6
    139 schema:url https://doi.org/10.1038/onc.2016.244
    140 sgo:license sg:explorer/license/
    141 sgo:sdDataset articles
    142 rdf:type schema:ScholarlyArticle
    143 N137e302b723d4f6f8cee72892dfc7b41 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name Heterografts
    145 rdf:type schema:DefinedTerm
    146 N19fa6482e4b346e7a49592b053aa0712 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Animals
    148 rdf:type schema:DefinedTerm
    149 N1e636ed48ea645508a1e1ff3737d4194 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Signal Transduction
    151 rdf:type schema:DefinedTerm
    152 N1ee2372d92954bcb92ad69f4d7a1e17e rdf:first sg:person.07476145564.93
    153 rdf:rest N956f45adce2c4133ac30b4ca14f7af56
    154 N216f0031848241a28e5542faa189ef9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name MAP Kinase Signaling System
    156 rdf:type schema:DefinedTerm
    157 N25f46e19cb304f639b8507cdb49308f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Mice, SCID
    159 rdf:type schema:DefinedTerm
    160 N2703ebf51dde4552b27c4d971fdccb5d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Oncogene Proteins, Fusion
    162 rdf:type schema:DefinedTerm
    163 N273b1aae677544e28575078642fea12f schema:affiliation grid-institutes:grid.413448.e
    164 schema:familyName Carlos Lázaro
    165 schema:givenName J
    166 rdf:type schema:Person
    167 N27cea2318f834c05baf922cbda096395 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Humans
    169 rdf:type schema:DefinedTerm
    170 N439e989860b340fb82d0ae9a30046014 rdf:first sg:person.010652500611.49
    171 rdf:rest Nc979c7bde547472080eb82133ff52b6d
    172 N49a13105f17a4426a9dbd9c645962d95 rdf:first sg:person.0650074000.01
    173 rdf:rest N6e17807f30f54a058caae339bdd2fffa
    174 N4deedafbaa2a485292d5c083062dcdcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Membrane Proteins
    176 rdf:type schema:DefinedTerm
    177 N4e501d6d4741407496dd5506eeb64374 rdf:first sg:person.01021230763.20
    178 rdf:rest N9dbe2af3f550461fbbe9f64bf9fe9f07
    179 N4ef54ad00612439d872f5fd9c4b1e1de rdf:first N273b1aae677544e28575078642fea12f
    180 rdf:rest N49a13105f17a4426a9dbd9c645962d95
    181 N563fc33cbe3a4c8d8cf81a5be0ade72c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Sarcoma, Ewing
    183 rdf:type schema:DefinedTerm
    184 N5dcf0c43e88b44e0b570dd0d644fda39 schema:name doi
    185 schema:value 10.1038/onc.2016.244
    186 rdf:type schema:PropertyValue
    187 N65681fd6e7484a0fb37101f8c491fe7e schema:volumeNumber 36
    188 rdf:type schema:PublicationVolume
    189 N6e17807f30f54a058caae339bdd2fffa rdf:first sg:person.010517700551.50
    190 rdf:rest N439e989860b340fb82d0ae9a30046014
    191 N76245a496984404e9c9ff2059d7eade4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name RNA-Binding Protein EWS
    193 rdf:type schema:DefinedTerm
    194 N7f412ed731ff481599058b37d96c9362 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Phosphoproteins
    196 rdf:type schema:DefinedTerm
    197 N7f585fa48b584570b4e8e1e1ee3317f6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Proto-Oncogene Protein c-fli-1
    199 rdf:type schema:DefinedTerm
    200 N814b5a532a364d37a9c852ce17541619 rdf:first sg:person.01046236753.12
    201 rdf:rest N4ef54ad00612439d872f5fd9c4b1e1de
    202 N8c28822bd1664677af21f484081dac45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name ras Proteins
    204 rdf:type schema:DefinedTerm
    205 N952bf331358a4d71b71536fd30c4c679 schema:affiliation grid-institutes:grid.413448.e
    206 schema:familyName López-Pérez
    207 schema:givenName S E
    208 rdf:type schema:Person
    209 N956f45adce2c4133ac30b4ca14f7af56 rdf:first sg:person.01014131131.48
    210 rdf:rest N814b5a532a364d37a9c852ce17541619
    211 N9bde318227cf4230b3a370a08bd39ed6 schema:name Springer Nature - SN SciGraph project
    212 rdf:type schema:Organization
    213 N9dbe2af3f550461fbbe9f64bf9fe9f07 rdf:first sg:person.01346440237.46
    214 rdf:rest Nb78cc751a56248c3a635fe845ed2349c
    215 Na6b11daddd5742038f75bac31f5be83d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Male
    217 rdf:type schema:DefinedTerm
    218 Nafe582d236f746d1b38e5cebbdc4a73d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    219 schema:name Mice
    220 rdf:type schema:DefinedTerm
    221 Nb4cb96cbfe5541c9bbc9854e8ee507aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    222 schema:name Female
    223 rdf:type schema:DefinedTerm
    224 Nb78cc751a56248c3a635fe845ed2349c rdf:first sg:person.012571320022.50
    225 rdf:rest rdf:nil
    226 Nbc577df8ad254915918581966cc962ef schema:name pubmed_id
    227 schema:value 27375017
    228 rdf:type schema:PropertyValue
    229 Nc979c7bde547472080eb82133ff52b6d rdf:first sg:person.01176025111.36
    230 rdf:rest Nee15f89984d342bc9035b5f15edc0d30
    231 Ncb2f4a1c7bdf41f18f854bb86b8d2147 schema:name dimensions_id
    232 schema:value pub.1018729222
    233 rdf:type schema:PropertyValue
    234 Ncbb76fd5f4ec46bdb3c4e295cc97ecad schema:issueNumber 6
    235 rdf:type schema:PublicationIssue
    236 Ne360ca9dd230448aba5dac50417ffe9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    237 schema:name Cell Line, Tumor
    238 rdf:type schema:DefinedTerm
    239 Nee15f89984d342bc9035b5f15edc0d30 rdf:first N952bf331358a4d71b71536fd30c4c679
    240 rdf:rest N4e501d6d4741407496dd5506eeb64374
    241 Nfb07bd4e1e8c48cdaede6162308037c6 rdf:first sg:person.01241144177.17
    242 rdf:rest N1ee2372d92954bcb92ad69f4d7a1e17e
    243 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    244 schema:name Medical and Health Sciences
    245 rdf:type schema:DefinedTerm
    246 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    247 schema:name Clinical Sciences
    248 rdf:type schema:DefinedTerm
    249 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    250 schema:name Oncology and Carcinogenesis
    251 rdf:type schema:DefinedTerm
    252 sg:journal.1097543 schema:issn 0950-9232
    253 1476-5594
    254 schema:name Oncogene
    255 schema:publisher Springer Nature
    256 rdf:type schema:Periodical
    257 sg:person.01014131131.48 schema:affiliation grid-institutes:grid.418596.7
    258 schema:familyName Surdez
    259 schema:givenName D
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014131131.48
    261 rdf:type schema:Person
    262 sg:person.01021230763.20 schema:affiliation grid-institutes:grid.452372.5
    263 schema:familyName Monzón
    264 schema:givenName S
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021230763.20
    266 rdf:type schema:Person
    267 sg:person.01046236753.12 schema:affiliation grid-institutes:grid.413448.e
    268 schema:familyName García-García
    269 schema:givenName L
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046236753.12
    271 rdf:type schema:Person
    272 sg:person.010517700551.50 schema:affiliation grid-institutes:grid.413448.e
    273 schema:familyName González-González
    274 schema:givenName L
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010517700551.50
    276 rdf:type schema:Person
    277 sg:person.010652500611.49 schema:affiliation grid-institutes:grid.81821.32
    278 schema:familyName Sastre
    279 schema:givenName A
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010652500611.49
    281 rdf:type schema:Person
    282 sg:person.01176025111.36 schema:affiliation grid-institutes:grid.81821.32
    283 schema:familyName García-Miguel
    284 schema:givenName P
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176025111.36
    286 rdf:type schema:Person
    287 sg:person.01241144177.17 schema:affiliation grid-institutes:grid.413448.e
    288 schema:familyName Cidre-Aranaz
    289 schema:givenName F
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241144177.17
    291 rdf:type schema:Person
    292 sg:person.012571320022.50 schema:affiliation grid-institutes:grid.413448.e
    293 schema:familyName Alonso
    294 schema:givenName J
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012571320022.50
    296 rdf:type schema:Person
    297 sg:person.01346440237.46 schema:affiliation grid-institutes:grid.418596.7
    298 schema:familyName Delattre
    299 schema:givenName O
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346440237.46
    301 rdf:type schema:Person
    302 sg:person.0650074000.01 schema:affiliation grid-institutes:grid.5252.0
    303 schema:familyName Kirchner
    304 schema:givenName T
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0650074000.01
    306 rdf:type schema:Person
    307 sg:person.07476145564.93 schema:affiliation grid-institutes:grid.5252.0
    308 schema:familyName Grünewald
    309 schema:givenName T G P
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07476145564.93
    311 rdf:type schema:Person
    312 sg:pub.10.1007/s13277-014-1665-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1020218086
    313 https://doi.org/10.1007/s13277-014-1665-y
    314 rdf:type schema:CreativeWork
    315 sg:pub.10.1038/13854 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041243219
    316 https://doi.org/10.1038/13854
    317 rdf:type schema:CreativeWork
    318 sg:pub.10.1038/359162a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008302153
    319 https://doi.org/10.1038/359162a0
    320 rdf:type schema:CreativeWork
    321 sg:pub.10.1038/nature11003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036060000
    322 https://doi.org/10.1038/nature11003
    323 rdf:type schema:CreativeWork
    324 sg:pub.10.1038/ncb0503-377 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045957077
    325 https://doi.org/10.1038/ncb0503-377
    326 rdf:type schema:CreativeWork
    327 sg:pub.10.1038/ng.1085 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025499740
    328 https://doi.org/10.1038/ng.1085
    329 rdf:type schema:CreativeWork
    330 sg:pub.10.1038/ng.3363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033290656
    331 https://doi.org/10.1038/ng.3363
    332 rdf:type schema:CreativeWork
    333 sg:pub.10.1038/onc.2008.203 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044394606
    334 https://doi.org/10.1038/onc.2008.203
    335 rdf:type schema:CreativeWork
    336 sg:pub.10.1038/onc.2011.556 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010799271
    337 https://doi.org/10.1038/onc.2011.556
    338 rdf:type schema:CreativeWork
    339 sg:pub.10.1038/sj.bjc.6605775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028392141
    340 https://doi.org/10.1038/sj.bjc.6605775
    341 rdf:type schema:CreativeWork
    342 sg:pub.10.1038/sj.onc.1201397 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004676244
    343 https://doi.org/10.1038/sj.onc.1201397
    344 rdf:type schema:CreativeWork
    345 sg:pub.10.1038/sj.onc.1206391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007451007
    346 https://doi.org/10.1038/sj.onc.1206391
    347 rdf:type schema:CreativeWork
    348 sg:pub.10.1186/1757-2215-7-61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032021446
    349 https://doi.org/10.1186/1757-2215-7-61
    350 rdf:type schema:CreativeWork
    351 grid-institutes:grid.413448.e schema:alternateName Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain
    352 schema:name Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain
    353 rdf:type schema:Organization
    354 grid-institutes:grid.418596.7 schema:alternateName INSERM U830 ‘Genetics and Biology of Cancers’ Institut Curie Research Center, Paris, France
    355 schema:name INSERM U830 ‘Genetics and Biology of Cancers’ Institut Curie Research Center, Paris, France
    356 rdf:type schema:Organization
    357 grid-institutes:grid.452372.5 schema:alternateName Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER U758), Instituto de Salud Carlos III, Madrid, Spain
    358 schema:name Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER U758), Instituto de Salud Carlos III, Madrid, Spain
    359 Unidad de Tumores Sólidos Infantiles, Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Majadahonda, Spain
    360 rdf:type schema:Organization
    361 grid-institutes:grid.5252.0 schema:alternateName Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany
    362 schema:name INSERM U830 ‘Genetics and Biology of Cancers’ Institut Curie Research Center, Paris, France
    363 Laboratory for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany
    364 rdf:type schema:Organization
    365 grid-institutes:grid.81821.32 schema:alternateName Unidad hemato-oncología pediátrica, Hospital Infantil Universitario La Paz, Madrid, Spain
    366 schema:name Unidad hemato-oncología pediátrica, Hospital Infantil Universitario La Paz, Madrid, Spain
    367 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...